Evidence map›Paper›PMID 29530028›Full record

ArticleBMC health services research2018

Patients' knowledge and attitudes to the Wise List - a drug formulary from the Stockholm Drug and Therapeutic committee.

Pia Bastholm-Rahmner, Lars L Gustafsson, Kristina Aggefors, Kristina Ateva, Susanne Elfving, Jaran Eriksen, Malena Jirlow, Maria Juhasz-Haverinen, Rickard E Malmström, Mahan Nikpour-Ardaly and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC health services research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Pia Bastholm-RahmnerMedical Management Centre, LIME, Karolinska Institutet, Tomtebodavägen 18 A, 171 77, Stockholm, Sweden. pia.bastholm.rahmner@ki.se.
Lars L GustafssonDivision of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital Huddinge, 141 86, Stockholm, Sweden.
Kristina AggeforsPublic Healthcare Services Committee, Box 17533, 118 91, Stockholm, Sweden.
Kristina AtevaStockholm Drug and Therapeutics Committee, Public Healthcare Services Committee, Box 17533, 118 91, Stockholm, Sweden.
Susanne ElfvingPublic Healthcare Services Committee, Box 17533, 118 91, Stockholm, Sweden.
Jaran EriksenDivision of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital Huddinge, 141 86, Stockholm, Sweden.
Malena JirlowPublic Healthcare Services Committee, Box 17533, 118 91, Stockholm, Sweden.
Maria Juhasz-HaverinenPublic Healthcare Services Committee, Box 17533, 118 91, Stockholm, Sweden.
Rickard E MalmströmClinical Pharmacology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, 171 76, Stockholm, Solna, Sweden.
Mahan Nikpour-ArdalyPublic Healthcare Services Committee, Box 17533, 118 91, Stockholm, Sweden.
Magnus RöjvallStockholm Drug and Therapeutics Committee, Public Healthcare Services Committee, Box 17533, 118 91, Stockholm, Sweden.
Martina VallinKarolinska Institutet, Department of Public Health Sciences, Tomtebodavägen 18A, Stockholm, Sweden.
Eva Andersén-KarlssonDepartment of Clinical Science and Education, Södersjukhuset, Internal Medicine, Karolinska Institutet, 118 83, Stockholm, Sweden.
Marie-Louise OvesjöDivision of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital Huddinge, 141 86, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInvolving patients in decisions about their pharmacotherapy is crucial for a satisfactory treatment outcome. Information and opinions about medicines are available from a variety of sources. The Wise List is the drug formulary of recommended essential medicines for the Stockholm healthcare region and is issued by the Drug and Therapeutics Committee (DTC). To inform the public about treatment for common diseases and the concept of recommended medicines, a patient edition of the Wise List was developed. The aim of this study was to explore patients' knowledge, needs and attitudes to the Wise List, DTC and information about medicines in general.

methodsTo examine patient knowledge about recommended medicines a survey (n = 312) was carried out at four large primary healthcare centres in Stockholm, Sweden. To further elucidate the patients' needs of the information on recommended medicines and medicines in general, three focus group discussions (FGDs) were performed.

resultsOf the respondents 57% did not recognise the Wise List, 26% recognised but did not use it and 17% used it. A total of 63% reported that they search for information about medicines. The most common information source was "asking their doctor" (36%) followed by searching the internet (31%). The FGDs revealed that the patients were not interested in medicines in general, only in the medicines they use themselves. They did not understand the aim of the Wise List or how they could benefit from information about recommended medicines. The patients expressed a wish to access all information they need about their own care as well as public healthcare information at one location.

conclusionThe intended aim of the DTC with providing information to the public was not achieved as the patients have difficulties to understand the information and how they should use it. The patients were not interested in medicines in general, they wanted information tailored to their specific needs. The findings highlight the importance of creating tools for patients in collaboration with them and evaluate the concept continuously.

Indexed as

Drugs, EssentialFormularies as TopicHealth Knowledge, Attitudes, PracticeAdolescentAdultAgedAged, 80 and overFemaleFocus GroupsHumansMaleMiddle AgedPatientsPharmacy and Therapeutics CommitteePractice Guidelines as TopicPrimary Health CareDrugs, EssentialDrug and Therapeutic committeeDrug formularyInformation sharingMedicine informationPatient educationSurvey interviewing

Identifiers

PMID29530028
PMCPMC5848508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.